REGENEREX PHARMA, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Regenerex Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q2 2024.
  • Regenerex Pharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$55.3K, a 54.4% increase year-over-year.
  • Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$458K, a 501% decline from 2022.
  • Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$76.2K, a 8.93% decline from 2021.
  • Regenerex Pharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$69.9K, a 11.6% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$55.3K +$65.9K +54.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q2 2023 -$121K -$86.2K -246% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q2 2022 -$35.1K -$12.6K -55.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q2 2021 -$22.5K -$13.4K -146% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q2 2020 -$9.13K -$26.8K -152% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 $17.7K +$16.8K +1846% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q2 2018 $910 -$16.2K -94.7% Apr 1, 2018 Jun 30, 2018 10-Q/A 2019-07-29
Q2 2017 $17.1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q3 2014 -$52.4K -$4.13K +$16K +79.5% Jun 1, 2014 Aug 31, 2014 10-Q 2014-10-20
Q2 2014 -$68.4K -$32.2K -$7.77K -31.8% Mar 1, 2014 May 31, 2014 10-Q/A 2014-07-23
Q1 2014 -$60.6K -$9.29K -$6.29K -210% Dec 1, 2013 Feb 28, 2014 10-Q 2014-04-11
Q4 2013 -$54.3K -$6.81K -$1.02K -17.6% Sep 1, 2013 Nov 30, 2013 10-K 2014-02-28
Q3 2013 -$53.3K -$20.1K +$8.3K +29.2% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-20
Q2 2013 -$61.6K -$24.4K -$15.4K -171% Mar 1, 2013 May 31, 2013 10-Q/A 2014-07-23
Q1 2013 -$46.2K -$3K +$11.5K +79.3% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-11
Q4 2012 -$57.7K -$5.8K Sep 1, 2012 Nov 30, 2012 10-K 2014-02-28
Q3 2012 -$28.4K Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-02
Q2 2012 -$9.01K +$4.55K +33.5% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 -$14.5K -$10.8K -290% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-12
Q2 2011 -$13.6K Mar 1, 2011 May 31, 2011 10-Q 2012-07-16
Q1 2011 -$3.72K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.